HIGHLIGHTS
- who: Failure and colleagues from the Department of Medicine, University of California San Diego, La Jolla, California, United States of America, Veterans Affairs San Diego Healthcare System, San Diego have published the paper: A Combined Screening Platform for HIV Treatment Failure and Resistance, in the Journal: (JOURNAL) of April/26,/2012
- what: Since the objective of this platform is to screen for levels of viremia likely to represent true ART failure ($1,000 copies/mL), further evaluation using more samples with viral loads within the range of interest is needed to define the true sensitivity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.